SANGSTAT
SangStat Medical Corporation, a global biopharmaceutical company, engages in the discovery, development, and marketing of therapeutic products for immunology, transplantation medicine, hematology/oncology, and autoimmune disorders.
SANGSTAT
Industry:
Biotechnology Manufacturing Medical
Founded:
1988-01-01
Address:
Fremont, California, United States
Country:
United States
Status:
Active
Contact:
(510) 789-4300
Similar Organizations
Biorthex
Biorthex designs, develops, manufactures and markets innovative and proprietary surgical products for the treatment of spinal disorders.
NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using
RITA Medical Systems, Inc
RITA Medical Systems develops, manufactures and markets innovative products for patients with solid cancerous or benign tumors.
Current Employees Featured
Founder
More informations about "SangStat" on Search Engine
SangStat Medical Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for SangStat Medical. Use the PitchBook Platform to explore the full profile.See details»
Genzyme to acquire SangStat - MarketWatch
"With this transaction, Genzyme is acquiring a profitable and growing company with a leading antibody product used in organ transplantation, a well-respected U.S. and …See details»
SangStat Medical Corporation Information - RocketReach
SangStat Medical Corporation is a Biotechnology, Pharmaceuticals, and Healthcare company_reader located in Fremont, California with $202000 in revenue and 0 …See details»
Sangstat Medical - Products, Competitors, Financials, Employees ...
Dec 14, 1993 About Sangstat Medical. Manufacturer of pharmaceuticals and monitoring devices for improving graft acceptance and organ transplantation. ALLOTRAP, the …See details»
Organization | Sangstat Medical Corporation - CDEK
Sangstat Medical Corporation. For profit Phase 2 Phase 3. Founded: Fremont CA United States (1988) Status: Acquired by Genzyme (2003) → now Sanofi-Aventis (2011) …See details»
Genzyme acquires SangStat - 2003-09-10 - Crunchbase
Summary. Overview. Acquired Organization: SangStat SangStat Medical develops, manufactures and markets a family of Bio-Pharmaceutical products which serve the …See details»
SANGSTAT MEDICAL CORPORATION - Dun & Bradstreet
Overview. Company Description: Key Principal: GEORGES GEMAYEL See more contacts. Industry: Other Ambulatory Health Care Services , Ambulatory Health Care Services , …See details»
SangStat Atlantique SAS - Company Profile and News
168.00. -1.38. SangStat Atlantique SAS. SangStat Atlantique was founded in 1990. The Company's line of business includes the manufacturing, fabricating, and processing of …See details»
SangStat Gets US Approval For Generic Cyclosporine
Mar 11, 1998 SangStat has been granted marketing approval in the USA for SangCya (cyclosporine 100mg/mL oral solution) for the prevention of rejection in solid organ …See details»
Sangstat: Drug Targets, Indications, Patents - Synapse
Dec 27, 2023 Basic Info. Drug Type. Unknown. Synonyms - Target - Mechanism - Therapeutic Areas. Congenital Disorders, Hemic and Lymphatic Diseases. Active …See details»
Genzyme to acquire SangStat for $600M - MarketWatch
NEW YORK (CBS.MW) -- Genzyme undefined has agreed to acquire SangStat undefined for about $600 million. The deal values SangStat shares at $22.50 each in...See details»
Genzyme Agrees to Purchase SangStat in $596 Million Deal
Aug 5, 2003 Genzyme Corp., as part of its effort to develop treatments for immune-system diseases, plans to acquire SangStat Medical Corp., whose leading product is an …See details»
In Brief: SangStat :: Medtech Insight
22 May 1995. News. Executive Summary. SangStat: Receives 510 (k) clearance for Cross-Stat, a monitoring assay that uses the firm's patented soluble human leukocyte antigen …See details»
SangStat Jumps 44% on Genzyme Deal - TheStreet
Aug 4, 2003 4:42 PM EDT. Updated from 12:17 p.m. EDT. Genzyme. ( GENZ) said Monday that it plans to acquire. SangStat Medical. ( SANG) , a biotechnology company …See details»
FDA: Abbott, SangStat can sell transplant drug - MarketWatch
SANG. +0.82% NEW YORK (CBS.MW) --Abbott Laboratories and SangStat said they received approval from the FDA to market Gengraf, a lower priced version of …See details»
Philippe Pouletty - Co-Founder and General Director - Crunchbase
Founder of SangStat (1988, organ transplantation therapeutics, IPO on NASDAQ in 1993, sold to Genzyme for $600M in 2002), Conjuchem (founded in 1993, IPO on the Toronto …See details»
| BioWorld
May 11, 1993. SangStat Medical Corp., a private biopharmaceutical company,announced its first significant corporate partnership onMonday to develop transplant-testing …See details»
Nationwide Recall of SangCya Oral Solution - JAMA Network
Editorial. The FDA has announced nationwide recall of SangCya oral solution (SangStat Medical Corp, Fremont, Calif), a generic version of the antirejection drug cyclosporine …See details»
SASTAT
SaSTAT is a world class training centre and an organization for SAS and Statistical services.See details»
SangStat - Updates, News, Events, Signals & Triggers
Sep 10, 2003 SangStat Medical develops, manufactures and markets a family of Bio-Pharmaceutical products which serve the organ transplantation market.See details»